Loading clinical trials...
Loading clinical trials...
Evaluation of the Empower Neuromodulation System for the Treatment of Alcohol Use Disorder
Conditions
Interventions
Empower Neuromodulation System
Locations
2
United States
University of California, San Francisco
San Francisco, California, United States
Yale University
New Haven, Connecticut, United States
Start Date
December 1, 2023
Primary Completion Date
August 6, 2025
Completion Date
August 6, 2025
Last Updated
August 11, 2025
NCT07027839
NCT06552741
NCT07279558
NCT07341230
NCT06676059
NCT05855668
Lead Sponsor
Theranova, L.L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions